HEADER TRANSFERASE 26-JUL-10 2XM8 TITLE CO-CRYSTAL STRUCTURE OF A SMALL MOLECULE INHIBITOR BOUND TO THE KINASE TITLE 2 DOMAIN OF CHK2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE CHK2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 210-531; COMPND 5 SYNONYM: CDS1, CHECKPOINT KINASE 2; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: ROSETTA2 DE3(PLYSS); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PTHREE-E KEYWDS TRANSFERASE, CANCER EXPDTA X-RAY DIFFRACTION AUTHOR J.J.CALDWELL,E.J.WELSH,C.MATIJSSEN,V.E.ANDERSON,L.ANTONI,K.BOXALL, AUTHOR 2 F.URBAN,A.HAYES,F.I.RAYNAUD,L.J.RIGOREAU,T.RAYNHAM,G.W.AHERNE, AUTHOR 3 L.H.PEARL,A.W.OLIVER,M.D.GARRETT,I.COLLINS REVDAT 3 20-DEC-23 2XM8 1 REMARK REVDAT 2 16-FEB-11 2XM8 1 AUTHOR JRNL REVDAT 1 12-JAN-11 2XM8 0 JRNL AUTH J.J.CALDWELL,E.J.WELSH,C.MATIJSSEN,V.E.ANDERSON,L.ANTONI, JRNL AUTH 2 K.BOXALL,F.URBAN,A.HAYES,F.I.RAYNAUD,L.J.RIGOREAU,T.RAYNHAM, JRNL AUTH 3 G.W.AHERNE,L.H.PEARL,A.W.OLIVER,M.D.GARRETT,I.COLLINS JRNL TITL STRUCTURE-BASED DESIGN OF POTENT AND SELECTIVE JRNL TITL 2 2-(QUINAZOLIN-2-YL)PHENOL INHIBITORS OF CHECKPOINT KINASE 2. JRNL REF J.MED.CHEM. V. 54 580 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 21186793 JRNL DOI 10.1021/JM101150B REMARK 2 REMARK 2 RESOLUTION. 3.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.63 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 11348 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.266 REMARK 3 R VALUE (WORKING SET) : 0.263 REMARK 3 FREE R VALUE : 0.323 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 532 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.6286 - 5.3893 0.99 2703 126 0.2477 0.3146 REMARK 3 2 5.3893 - 4.2818 1.00 2682 139 0.2590 0.2792 REMARK 3 3 4.2818 - 3.7417 1.00 2701 133 0.2623 0.3591 REMARK 3 4 3.7417 - 3.4001 1.00 2730 134 0.3186 0.3795 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.31 REMARK 3 B_SOL : 0.00 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.470 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 33.920 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 105.8 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -29.43130 REMARK 3 B22 (A**2) : -29.43130 REMARK 3 B33 (A**2) : 58.86250 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 1906 REMARK 3 ANGLE : 0.516 2614 REMARK 3 CHIRALITY : 0.036 311 REMARK 3 PLANARITY : 0.001 336 REMARK 3 DIHEDRAL : 14.956 583 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2XM8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-JUL-10. REMARK 100 THE DEPOSITION ID IS D_1290044786. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9330 REMARK 200 MONOCHROMATOR : DIAMOND (111), GE(220) REMARK 200 OPTICS : TOROIDAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 6154 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.000 REMARK 200 RESOLUTION RANGE LOW (A) : 39.330 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 7.420 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.0900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 7.69 REMARK 200 R MERGE FOR SHELL (I) : 0.50000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.530 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2CN5 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.89 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 0.2 M MAGNESIUM REMARK 280 NITRATE, 8-16% (W/V) PEG 3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 60.71333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 30.35667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 30.35667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 60.71333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -30.35667 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 203 REMARK 465 PRO A 204 REMARK 465 LEU A 205 REMARK 465 GLY A 206 REMARK 465 SER A 207 REMARK 465 HIS A 208 REMARK 465 MET A 209 REMARK 465 SER A 210 REMARK 465 GLY A 227 REMARK 465 SER A 228 REMARK 465 GLY A 229 REMARK 465 ALA A 230 REMARK 465 CYS A 231 REMARK 465 ILE A 251 REMARK 465 SER A 252 REMARK 465 LYS A 253 REMARK 465 ARG A 254 REMARK 465 LYS A 255 REMARK 465 PHE A 256 REMARK 465 ALA A 257 REMARK 465 ILE A 258 REMARK 465 GLY A 259 REMARK 465 SER A 260 REMARK 465 ALA A 261 REMARK 465 ARG A 262 REMARK 465 GLU A 263 REMARK 465 ALA A 264 REMARK 465 ASP A 265 REMARK 465 PRO A 266 REMARK 465 ALA A 267 REMARK 465 LEU A 268 REMARK 465 GLY A 376 REMARK 465 GLU A 377 REMARK 465 THR A 387 REMARK 465 PRO A 388 REMARK 465 THR A 389 REMARK 465 GLU A 504 REMARK 465 SER A 505 REMARK 465 THR A 506 REMARK 465 ALA A 507 REMARK 465 LEU A 508 REMARK 465 PRO A 509 REMARK 465 GLN A 510 REMARK 465 VAL A 511 REMARK 465 LEU A 512 REMARK 465 ALA A 513 REMARK 465 GLN A 514 REMARK 465 PRO A 515 REMARK 465 SER A 516 REMARK 465 THR A 517 REMARK 465 SER A 518 REMARK 465 ARG A 519 REMARK 465 LYS A 520 REMARK 465 ARG A 521 REMARK 465 PRO A 522 REMARK 465 ARG A 523 REMARK 465 GLU A 524 REMARK 465 GLY A 525 REMARK 465 GLU A 526 REMARK 465 ALA A 527 REMARK 465 GLU A 528 REMARK 465 GLY A 529 REMARK 465 ALA A 530 REMARK 465 GLU A 531 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 211 CG1 CG2 REMARK 470 LYS A 214 CG CD CE NZ REMARK 470 LEU A 216 CG CD1 CD2 REMARK 470 ARG A 217 CG CD NE CZ NH1 NH2 REMARK 470 MET A 222 CG SD CE REMARK 470 LYS A 224 CG CD CE NZ REMARK 470 THR A 225 OG1 CG2 REMARK 470 GLU A 233 CG CD OE1 OE2 REMARK 470 LYS A 235 CG CD CE NZ REMARK 470 GLU A 239 CG CD OE1 OE2 REMARK 470 LYS A 241 CG CD CE NZ REMARK 470 LYS A 244 CG CD CE NZ REMARK 470 LYS A 245 CG CD CE NZ REMARK 470 LYS A 249 CG CD CE NZ REMARK 470 ASN A 269 CG OD1 ND2 REMARK 470 VAL A 270 CG1 CG2 REMARK 470 ILE A 274 CG1 CG2 CD1 REMARK 470 GLU A 275 CG CD OE1 OE2 REMARK 470 LEU A 277 CG CD1 CD2 REMARK 470 LYS A 278 CG CD CE NZ REMARK 470 LYS A 279 CG CD CE NZ REMARK 470 LEU A 280 CG CD1 CD2 REMARK 470 ILE A 286 CG1 CG2 CD1 REMARK 470 LYS A 287 CG CD CE NZ REMARK 470 LYS A 289 CG CD CE NZ REMARK 470 ASN A 290 CG OD1 ND2 REMARK 470 PHE A 291 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP A 293 CG OD1 OD2 REMARK 470 GLU A 295 CG CD OE1 OE2 REMARK 470 ILE A 299 CG1 CG2 CD1 REMARK 470 GLU A 305 CG CD OE1 OE2 REMARK 470 LYS A 312 CG CD CE NZ REMARK 470 LYS A 317 CG CD CE NZ REMARK 470 LEU A 319 CG CD1 CD2 REMARK 470 LYS A 320 CG CD CE NZ REMARK 470 GLU A 321 CG CD OE1 OE2 REMARK 470 THR A 323 OG1 CG2 REMARK 470 LYS A 325 CG CD CE NZ REMARK 470 VAL A 335 CG1 CG2 REMARK 470 GLN A 336 CG CD OE1 NE2 REMARK 470 GLU A 340 CG CD OE1 OE2 REMARK 470 ASP A 347 CG OD1 OD2 REMARK 470 GLU A 359 CG CD OE1 OE2 REMARK 470 GLU A 360 CG CD OE1 OE2 REMARK 470 LEU A 363 CG CD1 CD2 REMARK 470 LYS A 373 CG CD CE NZ REMARK 470 ILE A 374 CG1 CG2 CD1 REMARK 470 LEU A 375 CG CD1 CD2 REMARK 470 THR A 378 OG1 CG2 REMARK 470 LEU A 380 CG CD1 CD2 REMARK 470 MET A 381 CG SD CE REMARK 470 ARG A 382 CG CD NE CZ NH1 NH2 REMARK 470 THR A 383 OG1 CG2 REMARK 470 LEU A 384 CG CD1 CD2 REMARK 470 VAL A 399 CG1 CG2 REMARK 470 ILE A 416 CG1 CG2 CD1 REMARK 470 GLU A 429 CG CD OE1 OE2 REMARK 470 ARG A 431 CG CD NE CZ NH1 NH2 REMARK 470 THR A 432 OG1 CG2 REMARK 470 GLN A 433 CG CD OE1 NE2 REMARK 470 SER A 435 OG REMARK 470 LYS A 437 CG CD CE NZ REMARK 470 ILE A 440 CG1 CG2 CD1 REMARK 470 THR A 441 OG1 CG2 REMARK 470 LYS A 444 CG CD CE NZ REMARK 470 GLU A 454 CG CD OE1 OE2 REMARK 470 SER A 456 OG REMARK 470 GLU A 457 CG CD OE1 OE2 REMARK 470 LYS A 458 CG CD CE NZ REMARK 470 LYS A 464 CG CD CE NZ REMARK 470 LYS A 465 CG CD CE NZ REMARK 470 VAL A 469 CG1 CG2 REMARK 470 LYS A 472 CG CD CE NZ REMARK 470 THR A 476 OG1 CG2 REMARK 470 GLU A 478 CG CD OE1 OE2 REMARK 470 GLN A 487 CG CD OE1 NE2 REMARK 470 GLU A 489 CG CD OE1 OE2 REMARK 470 ASP A 490 CG OD1 OD2 REMARK 470 MET A 491 CG SD CE REMARK 470 LYS A 492 CG CD CE NZ REMARK 470 ARG A 493 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 494 CG CD CE NZ REMARK 470 GLN A 496 CG CD OE1 NE2 REMARK 470 LEU A 498 CG CD1 CD2 REMARK 470 GLU A 501 CG CD OE1 OE2 REMARK 470 GLU A 502 CG CD OE1 OE2 REMARK 470 ASN A 503 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 217 -9.68 -56.77 REMARK 500 SER A 223 -116.82 -136.29 REMARK 500 LYS A 224 -163.84 -63.89 REMARK 500 CYS A 284 29.31 -79.01 REMARK 500 ASP A 293 -149.54 -105.78 REMARK 500 ALA A 294 169.87 62.35 REMARK 500 GLU A 295 -105.94 49.39 REMARK 500 ARG A 318 -175.21 56.45 REMARK 500 TYR A 327 -73.91 -49.08 REMARK 500 ASP A 347 56.94 -152.44 REMARK 500 SER A 356 -70.35 -75.96 REMARK 500 GLU A 359 154.88 -49.84 REMARK 500 THR A 367 -159.17 -125.52 REMARK 500 ASP A 368 71.91 52.75 REMARK 500 SER A 372 173.68 -54.25 REMARK 500 SER A 379 -37.30 -171.88 REMARK 500 LEU A 384 -176.41 -65.20 REMARK 500 CYS A 385 60.44 38.83 REMARK 500 LEU A 391 159.38 74.99 REMARK 500 TYR A 404 32.51 -86.00 REMARK 500 ARG A 431 -104.17 59.55 REMARK 500 THR A 432 -108.52 18.60 REMARK 500 GLN A 433 -164.56 144.27 REMARK 500 VAL A 434 131.39 63.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B4W A 1504 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WTI RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2XBJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2CN8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH REMARK 900 DEBROMOHYMENIALDISINE REMARK 900 RELATED ID: 2W0J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH NSC 109555 , A SPECIFIC REMARK 900 INHIBITOR REMARK 900 RELATED ID: 2WTC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2WTJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR REMARK 900 RELATED ID: 2XM9 RELATED DB: PDB REMARK 900 STRUCTURE OF A SMALL MOLECULE INHIBITOR WITH THE KINASE DOMAIN OF REMARK 900 CHK2 REMARK 900 RELATED ID: 2W7X RELATED DB: PDB REMARK 900 CELLULAR INHIBITION OF CHECKPOINT KINASE 2 AND POTENTIATION OF REMARK 900 CYTOTOXIC DRUGS BY NOVEL CHK2 INHIBITOR PV1019 REMARK 900 RELATED ID: 1GXC RELATED DB: PDB REMARK 900 FHA DOMAIN FROM HUMAN CHK2 KINASE IN COMPLEX WITH A SYNTHETIC REMARK 900 PHOSPHOPEPTIDE REMARK 900 RELATED ID: 2CN5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CHK2 IN COMPLEX WITH ADP REMARK 900 RELATED ID: 2WTD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CHK2 IN COMPLEX WITH AN INHIBITOR DBREF 2XM8 A 210 531 UNP O96017 CHK2_HUMAN 210 531 SEQADV 2XM8 GLY A 203 UNP O96017 EXPRESSION TAG SEQADV 2XM8 PRO A 204 UNP O96017 EXPRESSION TAG SEQADV 2XM8 LEU A 205 UNP O96017 EXPRESSION TAG SEQADV 2XM8 GLY A 206 UNP O96017 EXPRESSION TAG SEQADV 2XM8 SER A 207 UNP O96017 EXPRESSION TAG SEQADV 2XM8 HIS A 208 UNP O96017 EXPRESSION TAG SEQADV 2XM8 MET A 209 UNP O96017 EXPRESSION TAG SEQRES 1 A 329 GLY PRO LEU GLY SER HIS MET SER VAL TYR PRO LYS ALA SEQRES 2 A 329 LEU ARG ASP GLU TYR ILE MET SER LYS THR LEU GLY SER SEQRES 3 A 329 GLY ALA CYS GLY GLU VAL LYS LEU ALA PHE GLU ARG LYS SEQRES 4 A 329 THR CYS LYS LYS VAL ALA ILE LYS ILE ILE SER LYS ARG SEQRES 5 A 329 LYS PHE ALA ILE GLY SER ALA ARG GLU ALA ASP PRO ALA SEQRES 6 A 329 LEU ASN VAL GLU THR GLU ILE GLU ILE LEU LYS LYS LEU SEQRES 7 A 329 ASN HIS PRO CYS ILE ILE LYS ILE LYS ASN PHE PHE ASP SEQRES 8 A 329 ALA GLU ASP TYR TYR ILE VAL LEU GLU LEU MET GLU GLY SEQRES 9 A 329 GLY GLU LEU PHE ASP LYS VAL VAL GLY ASN LYS ARG LEU SEQRES 10 A 329 LYS GLU ALA THR CYS LYS LEU TYR PHE TYR GLN MET LEU SEQRES 11 A 329 LEU ALA VAL GLN TYR LEU HIS GLU ASN GLY ILE ILE HIS SEQRES 12 A 329 ARG ASP LEU LYS PRO GLU ASN VAL LEU LEU SER SER GLN SEQRES 13 A 329 GLU GLU ASP CYS LEU ILE LYS ILE THR ASP PHE GLY HIS SEQRES 14 A 329 SER LYS ILE LEU GLY GLU THR SER LEU MET ARG THR LEU SEQRES 15 A 329 CYS GLY THR PRO THR TYR LEU ALA PRO GLU VAL LEU VAL SEQRES 16 A 329 SER VAL GLY THR ALA GLY TYR ASN ARG ALA VAL ASP CYS SEQRES 17 A 329 TRP SER LEU GLY VAL ILE LEU PHE ILE CYS LEU SER GLY SEQRES 18 A 329 TYR PRO PRO PHE SER GLU HIS ARG THR GLN VAL SER LEU SEQRES 19 A 329 LYS ASP GLN ILE THR SER GLY LYS TYR ASN PHE ILE PRO SEQRES 20 A 329 GLU VAL TRP ALA GLU VAL SER GLU LYS ALA LEU ASP LEU SEQRES 21 A 329 VAL LYS LYS LEU LEU VAL VAL ASP PRO LYS ALA ARG PHE SEQRES 22 A 329 THR THR GLU GLU ALA LEU ARG HIS PRO TRP LEU GLN ASP SEQRES 23 A 329 GLU ASP MET LYS ARG LYS PHE GLN ASP LEU LEU SER GLU SEQRES 24 A 329 GLU ASN GLU SER THR ALA LEU PRO GLN VAL LEU ALA GLN SEQRES 25 A 329 PRO SER THR SER ARG LYS ARG PRO ARG GLU GLY GLU ALA SEQRES 26 A 329 GLU GLY ALA GLU HET B4W A1504 23 HETNAM B4W 2-{4-[(3S)-PYRROLIDIN-3-YLAMINO]QUINAZOLIN-2-YL}PHENOL FORMUL 2 B4W C18 H18 N4 O FORMUL 3 HOH *2(H2 O) HELIX 1 1 PRO A 213 GLU A 219 1 7 HELIX 2 2 ASN A 269 LEU A 280 1 12 HELIX 3 3 LEU A 309 VAL A 313 1 5 HELIX 4 4 LYS A 320 ASN A 341 1 22 HELIX 5 5 LYS A 349 GLU A 351 5 3 HELIX 6 6 SER A 379 LEU A 384 1 6 HELIX 7 7 ALA A 392 VAL A 399 1 8 HELIX 8 8 ARG A 406 GLY A 423 1 18 HELIX 9 9 SER A 435 GLY A 443 1 9 HELIX 10 10 ILE A 448 ALA A 453 1 6 HELIX 11 11 LYS A 458 LEU A 467 1 10 HELIX 12 12 THR A 476 HIS A 483 1 8 HELIX 13 13 PRO A 484 GLN A 487 5 4 SHEET 1 AA 5 TYR A 220 THR A 225 0 SHEET 2 AA 5 LYS A 235 GLU A 239 -1 O LEU A 236 N SER A 223 SHEET 3 AA 5 LYS A 245 LYS A 249 -1 O VAL A 246 N ALA A 237 SHEET 4 AA 5 TYR A 298 GLU A 302 -1 O ILE A 299 N LYS A 249 SHEET 5 AA 5 ILE A 288 PHE A 292 -1 N LYS A 289 O VAL A 300 SHEET 1 AB 3 GLY A 307 GLU A 308 0 SHEET 2 AB 3 VAL A 353 LEU A 355 -1 N LEU A 355 O GLY A 307 SHEET 3 AB 3 ILE A 364 ILE A 366 -1 O LYS A 365 N LEU A 354 SHEET 1 AC 2 ILE A 343 ILE A 344 0 SHEET 2 AC 2 LYS A 373 ILE A 374 -1 O LYS A 373 N ILE A 344 SITE 1 AC1 10 LEU A 226 GLY A 232 ALA A 247 LEU A 301 SITE 2 AC1 10 GLU A 302 LEU A 303 MET A 304 GLU A 308 SITE 3 AC1 10 GLU A 351 ASN A 352 CRYST1 90.110 90.110 91.070 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011098 0.006407 0.000000 0.00000 SCALE2 0.000000 0.012814 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010981 0.00000